ZEB1 Promotes Oxaliplatin Resistance through the Induction of Epithelial - Mesenchymal Transition in Colon Cancer Cells

Background: Oxaliplatin (OXA) chemotherapy is widely used in the clinical treatment of colon cancer. However, chemo-resistance is still a barrier to effective chemotherapy in cases of colon cancer. Accumulated evidence suggests that the epithelial mesenchymal transition (EMT) may be a critical facto...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Cao, Ma, Junli, Deng, Ganlu, Qu, Yanlin, Yin, Ling, Li, Yiyi, Han, Ying, Cai, Changjing, Shen, Hong, Zeng, Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687171/
https://www.ncbi.nlm.nih.gov/pubmed/29151941
http://dx.doi.org/10.7150/jca.20952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687171/
https://www.ncbi.nlm.nih.gov/pubmed/29151941
http://dx.doi.org/10.7150/jca.20952

Ejemplares similares